BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 9182910)

  • 1. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy.
    Pelletier JP; Caron JP; Evans C; Robbins PD; Georgescu HI; Jovanovic D; Fernandes JC; Martel-Pelletier J
    Arthritis Rheum; 1997 Jun; 40(6):1012-9. PubMed ID: 9182910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression.
    Fernandes J; Tardif G; Martel-Pelletier J; Lascau-Coman V; Dupuis M; Moldovan F; Sheppard M; Krishnan BR; Pelletier JP
    Am J Pathol; 1999 Apr; 154(4):1159-69. PubMed ID: 10233854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression.
    Caron JP; Fernandes JC; Martel-Pelletier J; Tardif G; Mineau F; Geng C; Pelletier JP
    Arthritis Rheum; 1996 Sep; 39(9):1535-44. PubMed ID: 8814066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
    Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Suppression of articular cartilage breakdown in osteoarthritis by interleukin-1 receptor antagonist using ex vivo gene therapy].
    Guo WS; Ma L; Li ZR
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):853-6. PubMed ID: 15200893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tenidap on the progression of osteoarthritic lesions in a canine experimental model. Suppression of metalloprotease and interleukin-1 activity.
    Fernandes JC; Caron JP; Martel-Pelletier J; Jovanovic D; Mineau F; Tardif G; Otterness IG; Pelletier JP
    Arthritis Rheum; 1997 Feb; 40(2):284-94. PubMed ID: 9041940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy.
    Nixon AJ; Haupt JL; Frisbie DD; Morisset SS; McIlwraith CW; Robbins PD; Evans CH; Ghivizzani S
    Gene Ther; 2005 Jan; 12(2):177-86. PubMed ID: 15578043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual transduction of insulin-like growth factor-I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model.
    Haupt JL; Frisbie DD; McIlwraith CW; Robbins PD; Ghivizzani S; Evans CH; Nixon AJ
    J Orthop Res; 2005 Jan; 23(1):118-26. PubMed ID: 15607883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic effects of tenidap in canine experimental osteoarthritis: relationship with biochemical markers.
    Jovanovic D; Caron JP; Martel-Pelletier J; Fernandes JC; Ricketts T; Pelletier JP
    J Rheumatol; 1997 May; 24(5):916-25. PubMed ID: 9150082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo dual inhibition of cyclooxygenase and lipoxygenase by ML-3000 reduces the progression of experimental osteoarthritis: suppression of collagenase 1 and interleukin-1beta synthesis.
    Jovanovic DV; Fernandes JC; Martel-Pelletier J; Jolicoeur FC; Reboul P; Laufer S; Tries S; Pelletier JP
    Arthritis Rheum; 2001 Oct; 44(10):2320-30. PubMed ID: 11665972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
    Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
    Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10.
    Zhang X; Mao Z; Yu C
    J Orthop Res; 2004 Jul; 22(4):742-50. PubMed ID: 15183429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-Modifying Osteoarthritis Treatment With Interleukin-1 Receptor Antagonist Gene Therapy in Small and Large Animal Models.
    Nixon AJ; Grol MW; Lang HM; Ruan MZC; Stone A; Begum L; Chen Y; Dawson B; Gannon F; Plutizki S; Lee BHL; Guse K
    Arthritis Rheumatol; 2018 Nov; 70(11):1757-1768. PubMed ID: 30044894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis.
    Pelletier JP; DiBattista JA; Raynauld JP; Wilhelm S; Martel-Pelletier J
    Lab Invest; 1995 May; 72(5):578-86. PubMed ID: 7745952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector.
    Roessler BJ; Hartman JW; Vallance DK; Latta JM; Janich SL; Davidson BL
    Hum Gene Ther; 1995 Mar; 6(3):307-16. PubMed ID: 7779914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine Model.
    Watson Levings RS; Smith AD; Broome TA; Rice BL; Gibbs EP; Myara DA; Hyddmark EV; Nasri E; Zarezadeh A; Levings PP; Lu Y; White ME; Dacanay EA; Foremny GB; Evans CH; Morton AJ; Winter M; Dark MJ; Nickerson DM; Colahan PT; Ghivizzani SC
    Hum Gene Ther Clin Dev; 2018 Jun; 29(2):101-112. PubMed ID: 29869535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of tenidap on canine experimental osteoarthritis: II. Study of the expression of collagenase-1 and interleukin 1beta by in situ hybridization.
    Fernandes JC; Martel-Pelletier J; Jovanovic D; Tardif G; DiBattista JA; Lascau-Coman V; Otterness IG; Pelletier JP
    J Rheumatol; 1998 May; 25(5):951-8. PubMed ID: 9598897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study.
    Chevalier X; Giraudeau B; Conrozier T; Marliere J; Kiefer P; Goupille P
    J Rheumatol; 2005 Jul; 32(7):1317-23. PubMed ID: 15996071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tenidap on canine experimental osteoarthritis. I. Morphologic and metalloprotease analysis.
    Fernandes JC; Martel-Pelletier J; Otterness IG; Lopez-Anaya A; Mineau F; Tardif G; Pelletier JP
    Arthritis Rheum; 1995 Sep; 38(9):1290-303. PubMed ID: 7575725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.